Hangzhou Alltest Biotech Co (SHSE:688606) Net Issuance of Preferred Stock : ¥0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Alltest Biotech Co Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Hangzhou Alltest Biotech Co's net issuance of preferred for the three months ended in Mar. 2024 was ¥0.0 Mil. The number is 0, which means that Hangzhou Alltest Biotech Co has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Hangzhou Alltest Biotech Co's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.0 Mil.

Hangzhou Alltest Biotech Co Net Issuance of Preferred Stock Historical Data

The historical data trend for Hangzhou Alltest Biotech Co's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Alltest Biotech Co Net Issuance of Preferred Stock Chart

Hangzhou Alltest Biotech Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Hangzhou Alltest Biotech Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Hangzhou Alltest Biotech Co Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Hangzhou Alltest Biotech Co Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Hangzhou Alltest Biotech Co's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Alltest Biotech Co (SHSE:688606) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hangzhou Alltest Biotech Co Ltd (SHSE:688606) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 550, Yinhai Street, Baiyang Street, Hangzhou Economic and Technological Development Zone, Building 3-5, Zhejiang Province, Hangzhou, CHN, 310018

Website

http://www.alltests.com.cn

Hangzhou Alltest Biotech Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents.

Executives

Fu Yan Ping	senior management
Lu Wei Ke	Directors, senior managers, core technical personn
Gao Fei	Directors, senior managers, core technical personn

Hangzhou Alltest Biotech Co (SHSE:688606) Headlines

No Headlines